NeueHealth, Inc.
NEUE
$6.82
-$0.03-0.44%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 29.30% | -11.75% | |||
| Total Other Revenue | -20.92% | 5.05% | |||
| Total Revenue | -7.24% | -0.13% | |||
| Cost of Revenue | -12.98% | 1.20% | |||
| Gross Profit | 14.97% | -4.96% | |||
| SG&A Expenses | -30.05% | 8.60% | |||
| Depreciation & Amortization | -1.19% | 2.80% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.42% | 3.12% | |||
| Operating Income | 110.46% | -46.71% | |||
| Income Before Tax | 96.92% | -85.89% | |||
| Income Tax Expenses | 116.52% | -124.06% | |||
| Earnings from Continuing Operations | 96.61% | -63.34% | |||
| Earnings from Discontinued Operations | -120.91% | 413.44% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 83.01% | 69.24% | |||
| Net Income | -331.26% | 95.26% | |||
| EBIT | 110.46% | -46.71% | |||
| EBITDA | 128.48% | -57.83% | |||
| EPS Basic | -49.73% | 77.22% | |||
| Normalized Basic EPS | 94.45% | 5.15% | |||
| EPS Diluted | -49.73% | 77.22% | |||
| Normalized Diluted EPS | 94.45% | 5.15% | |||
| Average Basic Shares Outstanding | 4.18% | -0.68% | |||
| Average Diluted Shares Outstanding | 4.18% | -0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||